化合物Flumatinib T4320
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 895519-90-1 | ¥1,170.00 | 询底价 |
1 mL | 895519-90-1 | ¥718.00 | 询底价 |
200 mg | 895519-90-1 | ¥3,490.00 | 询底价 |
5 mg | 895519-90-1 | ¥578.00 | 询底价 |
10 mg | 895519-90-1 | ¥747.00 | 询底价 |
1 mg | 895519-90-1 | ¥248.00 | 询底价 |
50 mg | 895519-90-1 | ¥1,580.00 | 询底价 |
100 mg | 895519-90-1 | ¥2,350.00 | 询底价 |
500 mg | 895519-90-1 | ¥5,570.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Flumatinib
描述: Flumatinib (HHGV678) 是一种具有口服活性的选择性 Bcr-Abl 抑制剂,能够作用于 c-Abl (IC50:1.2 nM),PDGFRβ (IC50:307.6 nM) 和 c-Kit (IC50:665.5 nM)。
体外活性: In higher concentration, HH-GV-678 can inhibit the phosphorylation of c-Kit in Mo7e cell and the phosphorylation of PDGFR in Swiss3T3 cell, however, HH-GV-678 has no or little effect on other tyrosine kinases including EGFR, KDR, c-Src and HER2. HH-GV-678 can predominantly inhibit the autophosphorylation of Bcr-Abl in K562 cell. Flumatinib effectively overcame the drug resistance of certain KIT mutants with activation loop mutations (i.e., D820 g, N822K, Y823D, and A829P).
体内活性: The purpose of this study was to identify the metabolites of flumatinib in CML patients, with the aim of determining the main metabolic pathways of lumatinib in humans after oral administration. Ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry revealed 34 metabolites; 7 primary metabolites were confirmed by comparison with synthetic reference standards. The results show that the parent drugflumatinib was the main form recovered in human plasma, urine, and feces. The main metabolites of flumatinib in humans were the products of N-demethylation, N-oxidation, hydroxylation, and amide hydrolysis
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (88.87 mM)
关键字: Inhibitor | HHGV 678 | HHGV-678 | Bcr-Abl | inhibit | Platelet-derived growth factor receptor | Flumatinib | PDGFR | CD117 | SCFR | c-Kit
相关产品: Olverembatinib | GNF-7 | CpCDPK1/TgCDPK1-IN-1 | Dasatinib monohydrate | AT9283 | Nilotinib | BCR-ABL-IN-8 | PP1 | Gypsogenin | Dasatinib
相关库: Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Cancer Approved Drug Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Active Compound Library
化合物Flumatinib T4320信息由TargetMol中国为您提供,如您想了解更多关于化合物Flumatinib T4320报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途